Tourette Syndrome and ADHD: Overlap, Assessment, and Treatment
Author: Angela Bogdanova · Published: October 12, 2026 · Editorial Policy
Research cluster: Tic Disorders, Tourette Syndrome & Repetitive Behaviors · Written by Artificial Sapiens
Tourette syndrome and attention-deficit/hyperactivity disorder (ADHD) frequently coexist. A person may experience recurrent involuntary movements or sounds alongside persistent difficulties with attention, impulse control, activity regulation, planning, or organization. Their combination can affect learning, relationships, employment, and emotional well-being. Accurate care requires understanding which symptoms belong to which condition, how they interact, and what most affects daily functioning. American Academy of Neurology guideline; European clinical assessment guideline.
Clinical guidelines recommend that people with tics be assessed for ADHD and that impairing ADHD receive appropriate treatment. They also emphasize assessing tic severity and impact on their own terms. The goal is a coordinated plan in which each treatment has a clear target, risks are monitored, and the person has a meaningful role in decisions. AAN guideline; AAP ADHD guideline.
Can Tourette syndrome and ADHD occur together?
Yes. Tourette syndrome and ADHD are separate neurodevelopmental diagnoses that may occur in the same child, adolescent, or adult. A person with Tourette syndrome can have typical attention and executive functioning, and a person with ADHD can have no tic symptoms. The presence of one diagnosis does not automatically establish the other. CDC: Other concerns and conditions.
The overlap matters because functional impairment may be driven by either condition or by their combined demands. Someone with mild tics may have marked difficulty sustaining attention and completing tasks; another person with controlled ADHD symptoms may still have painful motor tics, disruptive vocal tics, or social distress. Treatment priorities should follow what actually interferes with the person's life rather than how visible one symptom appears to outsiders. AAN guideline.
How common is ADHD in Tourette syndrome?
The American Academy of Neurology describes ADHD in approximately 30%–50% of people with Tourette syndrome. Referral-based clinical studies sometimes report higher figures; prevalence depends on the population, assessment method, age, and whether investigators measure current or lifetime diagnoses. A statistic drawn from a specialty clinic should not be generalized uncritically to the entire community. AAN guideline; ESSTS pharmacological guideline.
A large family-based study of 1,374 participants with Tourette syndrome found that 85.7% had at least one lifetime psychiatric comorbidity and 72.1% had experienced ADHD or OCD. The latter is a combined category, not the rate of ADHD alone. The study demonstrates the importance of a broad clinical assessment while also illustrating the difference between lifetime and current symptom burden. Hirschtritt and colleagues.
Understanding Tourette syndrome
Tourette syndrome is characterized by multiple motor tics and at least one vocal tic at some point during the condition, with onset before age 18 and more than one year elapsed since the first tic. Motor and vocal tics do not need to occur at the same moment. The evaluating clinician considers other medical explanations and substance-related movements. Provisional tic disorder and persistent motor or vocal tic disorder have different criteria; an isolated tic does not automatically constitute Tourette syndrome. CDC: Diagnosing tic disorders. For further detail, read Tourette Syndrome: Symptoms, Causes, Diagnosis, and Treatment.
Tics are recurrent, typically sudden and nonrhythmic movements or vocalizations. Simple motor tics include blinking and facial contractions; complex motor tics involve more elaborate movements. Simple vocal tics include throat clearing, sniffing, and grunting, while complex vocal tics can involve syllables or phrases. Many patients describe premonitory sensory urges, and some can suppress tics briefly, often with effort or discomfort. Tic frequency, complexity, and intensity naturally wax and wane. ESSTS assessment guideline.
Coprolalia, or involuntary socially inappropriate language, occurs in a minority of people with Tourette syndrome. It is neither required for diagnosis nor an accurate summary of the condition. Similarly, the absence of observable tics during a consultation does not negate a well-documented history; clinic settings can alter symptom expression. CDC: About Tourette syndrome; ESSTS assessment guideline.
Understanding ADHD
ADHD involves a persistent and developmentally inappropriate pattern of inattention and/or hyperactivity-impulsivity with meaningful functional consequences. DSM-based diagnosis requires symptoms lasting at least six months, several present before age 12, evidence in at least two settings, and impairment. Symptom-count thresholds vary by age. A clinician considers sleep disorders, anxiety, learning differences, medication effects, and other explanations before concluding that ADHD criteria are fulfilled. CDC: ADHD clinical guidance; AAP guideline.
Inattention can include losing track of instructions, misplacing necessary objects, poor organization, inconsistent sustained effort, and frequent task abandonment. Hyperactivity-impulsivity can include broad restlessness, difficulty waiting, excessive movement, interrupting others, and acting before considering consequences. Occasional distraction or activity is part of ordinary life; a diagnosis concerns a sustained, cross-context developmental pattern. CDC: Diagnosing ADHD.
How Tourette syndrome and ADHD symptoms overlap
Motor tics versus ADHD restlessness
ADHD-related fidgeting often involves generalized activity, repeated posture changes, or movement during tasks that demand sustained attention. Motor tics more often form recognizable, sudden, recurrent movement patterns that appear in bouts and fluctuate. A person can display both, and a brief video cannot reliably establish which mechanism is operating. Clinicians consider age at onset, typical sequence, premonitory urges, contexts, and the person's description of the movement. ESSTS assessment guideline.
Inattention versus the cognitive cost of tics
A person with repeated tics may lose their place while reading or taking notes. Someone trying to suppress tics may devote considerable attention to that task. ADHD, meanwhile, can impair attention regulation in situations with few or no tics. Clinicians look for enduring developmental attention difficulties across settings and ask how concentration changes when tic burden changes. The experiences may reinforce one another without becoming the same symptom. ESSTS assessment guideline; CDC guidance for educators.
Vocal tics versus impulsive interruptions
A vocal tic may resemble an interruption, while ADHD-related impulsivity can lead someone to speak before another person finishes. The resemblance can prompt misinterpretation as defiance or deliberate misconduct. A clinician asks whether a particular sound or phrase is recurrent and patterned, whether there is an urge preceding it, and whether broader impulse-control difficulties occur outside tic episodes. ESSTS assessment guideline.
Executive functioning and learning difficulties
Planning, time management, task initiation, and working-memory demands can become difficult when ADHD accompanies tics. Tourette syndrome may also interfere mechanically with writing, speaking, or completing an examination. Neuropsychological testing can help answer selected questions about learning or cognition, but is not mandatory for every diagnosis and should be directed toward a real clinical question. ESSTS assessment guideline.
Why do the conditions co-occur?
Tourette syndrome and ADHD each have substantial neurodevelopmental and familial components. Clinical and genetic research suggests partly overlapping risk factors involving networks important for action regulation, movement, attention, and behavioral control. Evidence of overlap at the population level is not a single biological explanation for every person's presentation, nor does it provide a stand-alone blood test or brain scan for either diagnosis. Hirschtritt et al.; ESSTS assessment guideline.
Environmental circumstances can affect symptom expression. Stress, fatigue, excitement, social attention, and efforts to suppress tics may change how often tics occur or how disruptive they feel. Such factors do not prove that parenting, motivation, emotional distress, or screen exposure caused Tourette syndrome. A contextual trigger and an underlying neurodevelopmental diagnosis answer different clinical questions. ESSTS psychological-interventions guideline.
How clinicians assess Tourette syndrome and ADHD together
Developmental history and onset
The assessment reconstructs when motor and vocal tics first appeared, their duration, evolution, and degree of impairment. It separately documents the onset of inattentive or hyperactive-impulsive symptoms, their occurrence before age 12, and their persistence across contexts. Caregiver observations, school reports, available records, and the patient's own account may clarify how each pattern developed. CDC: Tic diagnosis; AAP guideline.
Interview and medical differential
The clinician assesses tic-related discomfort, urges, suppression, injury, sleep, medication exposure, mood, anxiety, compulsions, academic performance, family history, and learning difficulties. Physical or neurologic examination is guided by the presentation. EEG, neuroimaging, and laboratory studies generally do not establish typical Tourette syndrome or ADHD; they are used when the history or examination raises a specific medical concern. ESSTS assessment guideline.
Rating scales and their limits
The clinician-rated Yale Global Tic Severity Scale (YGTSS) documents dimensions of tics and their impact. The Premonitory Urge for Tics Scale (PUTS) offers supplementary information about sensory urges. Age-appropriate ADHD instruments, including SNAP and Conners scales, contribute standardized descriptions from patients, caregivers, or educators. They assist assessment and treatment monitoring. A scale score is not, by itself, a diagnosis, and no single score fully separates tics, fidgeting, compulsions, and other movement presentations. ESSTS assessment guideline. For further detail, read Yale Global Tic Severity Scale (YGTSS).
Functional impact matters more than the number of symptoms alone
The assessor asks for concrete difficulties: unfinished work, classroom disruptions, pain, exhaustion, handwriting problems, missed instructions, peer conflicts, and stress generated by suppressing tics. An observer may underestimate effort or distress when symptoms are hidden. Multi-informant evaluation and repeated measurement help establish which problems are persistent, impairing, and responsive to intervention. AAN guideline; AAP guideline.
Other conditions that should be considered
OCD, anxiety, sleep disorders, autism, mood disorders, and learning disorders may coexist with Tourette syndrome and ADHD. Repetitive actions tied to intrusive fears or rigid rules may represent compulsions; stereotyped sensory-regulatory movement has a different clinical profile from some tics. New or unusual involuntary movements warrant differential assessment for neurologic, medication-related, and functional causes. Diagnostic uncertainty is addressed by careful history and observation rather than labeling every repetitive action a tic. ESSTS assessment guideline.
Functional tic-like behaviors are genuine symptoms that require respectful evaluation and can occasionally coexist with developmental tic disorders. They should never be equated automatically with fabrication. The related OCD-owned English Hub articles OCD and Tic Disorders: What Is the Connection? and OCD vs Tourette Syndrome examine compulsions and their diagnostic boundaries. ESSTS assessment guideline.
Treatment starts with impairment and personal priorities
Tourette tics that are mild and do not cause meaningful pain, distress, or interference may warrant education, observation, and support rather than active treatment. Functionally impairing ADHD deserves appropriate care whether or not tics are prominent. Conversely, disabling tics may need specific therapy even when attention and impulse control are adequately managed. The AAN recommends assessing ADHD burden and treating impairing ADHD in people with tics. AAN guideline.
Shared decisions establish separate goals for tic frequency and interference, school or work functioning, attention, impulse control, sleep, and quality of life. The natural waxing and waning of tics can complicate judgments about medication, so the plan should use reasonable baseline observations and follow-up rather than attributing every change to a treatment. ESSTS pharmacological guideline. For further detail, read How to Manage Tics in Daily Life.
CBIT for clinically impairing tics
Comprehensive Behavioral Intervention for Tics (CBIT) has the strongest psychological treatment evidence for chronic tics in modern clinical guidelines. Habit reversal training, a key component, involves awareness training and developing a competing response; the broader treatment also addresses contextual patterns affecting tic expression. It teaches practical skills for managing tics. The purpose is symptom relief and improved autonomy, not forcing an individual to hide symptoms for someone else's comfort. ESSTS psychological guideline; AAN guideline.
Co-occurring ADHD can complicate homework completion or sustained participation in therapy. Clinicians may adapt session structure, simplify practice tasks, use visual reminders, and coordinate caregiver support. Such adjustments are clinically reasonable but should not be claimed to constitute a universally validated combined treatment protocol. Evidence for CBIT addresses tics; ADHD symptoms still require their own interventions. ESSTS psychological guideline.
Tic-focused exposure and response prevention is also described in European guidelines, though supported by a smaller research base. Its treatment target differs from OCD-focused ERP. Selection depends on the individual's symptoms, preferences, age, capacity for practice, access to trained clinicians, and response to previous care. ESSTS psychological guideline.
Behavioral care and school support for ADHD
Behavioral treatment for ADHD may include parent training in behavior management, classroom-based strategies, structured organizational assistance, clear task instructions, external reminders, and predictable routines. For children ages four to six, AAP guidance emphasizes parent training and/or classroom interventions initially, with medication considered under specified conditions. For older children and adolescents, an indicated medication and behavioral or educational support are frequently combined. AAP guideline; CDC: ADHD treatment.
The school plan should also accommodate tic-related needs, such as breaks, handwriting adjustments, seating, and privacy. The educational goal is access and participation. Repeated punishment for involuntary tics or predictable ADHD-related disabilities can intensify functional difficulty; positive, individualized responses are more appropriate. CDC: Information for educators.
Do ADHD stimulants make Tourette tics worse?
A diagnosis of Tourette syndrome is not automatically a contraindication to stimulant treatment for ADHD. The Cochrane systematic review and AAN guideline found that methylphenidate can improve ADHD symptoms in children with chronic tics without consistently worsening tics relative to placebo. Tics may nevertheless increase in individual patients, and natural symptom fluctuations make causal interpretation challenging. Decisions require individualized medication selection, careful titration, and observation. Cochrane review; AAN guideline.
In a randomized trial involving 136 children with ADHD and chronic tics, methylphenidate, clonidine, and their combination improved ADHD outcomes versus placebo, with results that challenged broad historical warnings against stimulants in this population. The study was limited in duration and population, so its results should not be generalized to every adult, dose, stimulant formulation, or new-onset tic-like presentation. Tourette Syndrome Study Group.
The evidence is less uniform for some amphetamine regimens. One short high-dose dextroamphetamine trial suggested tic worsening, and tic increases sometimes limited dose escalation. Appetite changes, sleep difficulties, mood, cardiovascular measures, and observed tic changes all merit review during ADHD medication titration. Treatment should never be changed or stopped abruptly without discussion with the prescribing clinician. Cochrane review.
Nonstimulant medication options
Clonidine and guanfacine
Alpha-2 adrenergic agonists such as clonidine and guanfacine may improve both ADHD symptoms and tics in children who have both conditions. They are particularly relevant when the two symptom domains are simultaneously important, while the magnitude of benefit and tolerability differ by patient and study. The AAN recommends counseling families about potential dual benefits and monitoring adverse effects. AAN guideline; ESSTS pharmacological guideline.
Potential adverse effects include sedation, fatigue, dizziness, low blood pressure, and low heart rate. Clinicians monitor pulse and blood pressure and address any relevant cardiac concerns. Abrupt discontinuation can produce rebound hypertension, making prescriber-supervised tapering essential. AAN guideline.
Atomoxetine
Atomoxetine is a nonstimulant ADHD medication that improves ADHD symptoms and did not worsen tics relative to placebo in the pediatric tic-plus-ADHD trials reviewed by the AAN. It may be an option when stimulants are not preferred or are difficult to tolerate. Its adverse effects, warnings, and response still require individual clinical review. It should not be described as a proven universal treatment for Tourette tics themselves. AAN guideline; Cochrane review.
Combining medication and therapy
A clinician may combine ADHD medication with CBIT or other appropriate tic treatment. Some pediatric evidence supports combined methylphenidate and clonidine in selected children, but no trial establishes that every medication combination is safe or optimal. Additional drugs add monitoring demands and potential adverse effects. A treatment strategy should remain clear about which symptom each intervention addresses. Tourette Syndrome Study Group; ESSTS pharmacological guideline.
Medication directed specifically at tics
When tics cause substantial pain, injury, distress, or interference, tic-specific medications may be considered alongside behavioral treatment or when behavioral care is not available or adequate. European guidelines discuss agents such as aripiprazole and other dopamine-modulating medicines, taking into account possible movement-related, metabolic, sedating, and other adverse effects. These medications should not be confused with routine ADHD treatments. Their use involves individualized specialist judgment and monitoring. ESSTS pharmacological guideline; AAN guideline. For further detail, read Medications for Tourette Syndrome and Tics.
Specialist interventions for severe refractory tics involve additional safeguards and are relevant to a small, carefully evaluated subgroup. Improving tic severity alone is insufficient if the treatment substantially worsens alertness, mood, learning, or daily participation. Evaluation therefore weighs total functional benefit. AAN guideline.
School accommodations, Section 504, and IEPs
In U.S. schools, a student whose Tourette syndrome and ADHD limit educational access may be eligible for a Section 504 plan or special education services under an individualized education program (IEP), depending on applicable criteria. Supports can include predictable instructions, separate or extended testing arrangements where justified, tic breaks, reduced handwriting burden, task chunking, organizational support, and attention to bullying. Eligibility and accommodations depend on educational need, not the mere existence of two diagnoses. CDC: Tourette treatment and school services; CDC: ADHD clinical care.
The student's perspective about privacy, disclosure, peer reactions, and preferred supports should be incorporated. Teaching staff about involuntary symptoms can reduce misunderstanding, while an individualized plan avoids requiring a student to expend all their attention suppressing tics. CDC: Educator information.
Adolescence, adulthood, and long-term prognosis
For many people, tics peak during late childhood and diminish in adolescence or early adulthood, although they may persist. ADHD can also change in presentation, with childhood hyperactivity sometimes becoming subjective restlessness or organization problems. Changes in one condition do not guarantee parallel changes in the other; follow-up evaluates functioning and current needs across the life course. ESSTS psychological guideline; AAN guideline.
Adult assessment often reconstructs childhood history from old records or family observations and examines current work, relationships, sleep, executive functioning, and treatments. ADHD may remain functionally significant when tics become less visible. Adult-specific evidence for some combined treatment regimens is limited, so pediatric findings require careful interpretation. ESSTS assessment guideline; CDC: ADHD in adults.
Family relationships and mental health
Families may face intertwined challenges such as homework conflict, transitions, uncomfortable tics, impulsive speech, sleep disruption, and misunderstanding by others. Clear routines, collaborative planning, and psychoeducation can support communication without turning involuntary movements into a discipline issue. Anxiety, depression, OCD, learning disorders, and bullying may need their own assessment and treatment. CDC: Other concerns and conditions; ESSTS assessment guideline.
A person may also feel pressure to hide tics or explain ADHD-related mistakes repeatedly. Treatment discussions should include pain, fatigue, stigma, motivation, emotional well-being, and the person's own priorities. Symptom reduction is meaningful when it supports comfort and participation in everyday life. AAN guideline.
When to seek assessment or urgent medical attention
A clinical assessment is appropriate for recurrent motor or vocal symptoms, attention or impulsivity difficulties across settings, pain, injury, school interference, or significant social distress. Qualified clinicians may include pediatricians, psychiatrists, neurologists, psychologists, and relevant developmental specialists. Their roles depend on local services and the complexity of the case. CDC: Tic diagnosis; CDC: ADHD diagnosis.
Sudden-onset atypical movements, episodes involving altered consciousness, new neurologic deficits, or symptoms closely tied to medication changes deserve prompt medical evaluation rather than automatic attribution to Tourette syndrome. Assessment may identify other movement disorders, functional symptoms, seizures, or medical issues. Functional tic-like behaviors are real and should be approached respectfully, with attention to the positive features of the clinical presentation. ESSTS assessment guideline.
Questions to ask at an appointment
The most useful questions concern separate symptom patterns and clear treatment targets. How long have motor and vocal tics been present? Does inattention persist when tics are minimal? Which daily activities are most impaired? Are sleep, anxiety, OCD, or learning difficulties contributing? Which treatment has evidence for this person's age and presentation? What side effects need monitoring? What school or workplace supports would improve access? AAN guideline; AAP guideline.
Documenting the functional response to each treatment helps distinguish meaningful improvement from the spontaneous waxing and waning of tics. Medication monitoring should address both benefit and adverse effects, while behavioral care is evaluated by real changes in comfort, participation, and autonomy. ESSTS pharmacological guideline.
Evidence strength and research limitations
Strong clinical guidance supports assessing and treating functionally impairing ADHD in people with tics; psychoeducation and CBIT have established roles in tic care. Pediatric studies support selected stimulants, alpha-2 agonists, and atomoxetine for ADHD with co-occurring tics, but their precision and quality vary by drug and outcome. The Cochrane review reported low to very low certainty across several medication comparisons, and larger long-term head-to-head studies remain needed. AAN guideline; Cochrane review.
Study populations are frequently selected pediatric groups, and short-term tic severity is not the same outcome as long-term quality of life. Evidence about Tourette syndrome cannot simply be carried over to sudden-onset functional tic-like symptoms. Promising biological explanations and practical adaptations should be distinguished from interventions demonstrated effective in randomized trials. ESSTS assessment guideline; ESSTS pharmacological guideline.
Frequently asked questions
Is ADHD part of Tourette syndrome?
ADHD is a separate diagnosis that frequently accompanies Tourette syndrome. Both require their own assessment, and ADHD-related impairment can be greater than tic-related impairment in some individuals. AAN guideline.
Does Tourette syndrome cause ADHD?
Co-occurrence and partially shared developmental risk do not demonstrate that tics themselves cause ADHD. A clinician evaluates each developmental condition independently. Hirschtritt et al..
Is every repeated movement a tic?
No. Repetitive movement can involve ADHD-related fidgeting, stereotypies, stimming, compulsions, functional tic-like symptoms, medication effects, or other neurologic phenomena. A clinical history and examination distinguish relevant patterns. ESSTS assessment guideline.
Can a person have tics without Tourette syndrome?
Yes. Tic symptoms also occur in provisional and persistent motor or vocal tic disorders. Tourette syndrome requires both motor and vocal tics during its course and the relevant history and duration criteria. CDC: Tic disorders.
Can children with tics take stimulants for ADHD?
When medically appropriate, yes. Methylphenidate has pediatric evidence for improving ADHD symptoms without consistent tic exacerbation, although individual reactions and side effects require review. Cochrane review.
Do clonidine and guanfacine treat both conditions?
These agents can help both ADHD symptoms and tics in some children, with potential sedation and cardiovascular effects requiring supervision. The right treatment depends on the individual. AAN guideline.
Does CBIT treat ADHD too?
CBIT targets tics. ADHD-specific behavioral, educational, and medication treatments may be needed alongside it. Therapy can be adapted to support someone with attention and organization difficulties. ESSTS psychological guideline.
Does every student with Tourette syndrome and ADHD need an IEP?
School supports are based on individual educational impact and the relevant U.S. eligibility requirements. Some students qualify for an IEP; others benefit from Section 504 accommodations or general classroom interventions. CDC: School support.
Will both conditions go away during adulthood?
Tics improve for many people over time, but can persist. ADHD may remain impairing or shift in how it presents. Adult care depends on current symptoms, history, and functioning. AAN guideline.
Must mild tics always be treated?
No. Education and monitoring may be appropriate when tics cause little impairment. Functionally impairing ADHD or another co-occurring condition can still need treatment. AAN guideline.
Conclusion
Tourette syndrome and ADHD can coexist with overlapping outward behaviors and distinct clinical mechanisms. Care begins by separating tics from broader restlessness, evaluating developmental ADHD criteria, identifying the sources of impairment, and listening to the person's priorities. An effective plan may use education, CBIT, ADHD-specific behavioral care, school or workplace supports, and carefully monitored medication. The measure of success is improved functioning, comfort, and participation across life settings. AAN guideline; ESSTS assessment guideline.
Related Articles
References
Centers for Disease Control and Prevention. (2026). Diagnosing ADHD. https://www.cdc.gov/adhd/diagnosis/index.html
Centers for Disease Control and Prevention. (2026). Diagnosing tic disorders. https://www.cdc.gov/tourette-syndrome/diagnosis/
Centers for Disease Control and Prevention. (2026). Clinical care of ADHD in children. https://www.cdc.gov/adhd/hcp/treatment-recommendations/
Centers for Disease Control and Prevention. (2026). Information about Tourette syndrome for educators. https://www.cdc.gov/tourette-syndrome/info-for-educators/index.html
Centers for Disease Control and Prevention. (2026). Treatment of ADHD. https://www.cdc.gov/adhd/treatment/index.html
Centers for Disease Control and Prevention. (2024). Treatment of Tourette syndrome. https://www.cdc.gov/tourette-syndrome/treatment/index.html
Centers for Disease Control and Prevention. (2026). Other concerns and conditions of Tourette syndrome. https://www.cdc.gov/tourette-syndrome/other-concerns/index.html
Hirschtritt, M. E., Lee, P. C., Pauls, D. L., et al. (2015). Lifetime prevalence, age of risk, and genetic relationships of comorbid psychiatric disorders in Tourette syndrome. JAMA Psychiatry, 72(4), 325–333. https://doi.org/10.1001/jamapsychiatry.2014.2650
Andrén, P., Jakubovski, E., Murphy, T. L., et al. (2022). European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part II: psychological interventions. European Child & Adolescent Psychiatry, 31, 403–423. https://doi.org/10.1007/s00787-021-01845-z
Roessner, V., Eichele, H., Stern, J. S., et al. (2022). European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part III: pharmacological treatment. European Child & Adolescent Psychiatry, 31, 425–441. https://doi.org/10.1007/s00787-021-01899-z
Wolraich, M. L., Hagan, J. F., Allan, C., et al. (2019). Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit/hyperactivity disorder in children and adolescents. Pediatrics, 144(4), e20192528. https://doi.org/10.1542/peds.2019-2528
Tourette Syndrome Study Group. (2002). Treatment of ADHD in children with tics: A randomized controlled trial. Neurology, 58(4), 527–536. https://doi.org/10.1212/WNL.58.4.527
Pringsheim, T., Okun, M. S., Müller-Vahl, K., et al. (2019). Practice guideline recommendations summary: Treatment of tics in people with Tourette syndrome and chronic tic disorders. Neurology, 92, 896–906. https://doi.org/10.1212/WNL.0000000000007466
Osland, S. T., Steeves, T. D. L., & Pringsheim, T. (2018). Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders. Cochrane Database of Systematic Reviews, CD007990. https://doi.org/10.1002/14651858.CD007990.pub3
Szejko, N., Robinson, S., Hartmann, A., et al. (2022). European clinical guidelines for Tourette syndrome and other tic disorders—version 2.0. Part I: assessment. European Child & Adolescent Psychiatry, 31, 383–402. https://doi.org/10.1007/s00787-021-01842-2